Acute pulmonary embolism is a life-threatening condition because it places sudden strain on the right ventricle of the heart.

The small-profile device expands to capture clots like large-bore systems while offering good reduction in RV/LV ratio at 48 ...

USA: Results from the pivotal STORM-PE randomized controlled trial, presented as a Late-Breaking Clinical Trial at TCT 2025, ...

The landscape of coronary and pulmonary vascular medicine is undergoing a paradigm shift, fueled by breakthroughs in molecular biology, imaging, and ...

Jupiter Endovascular, which was formed by Neptune Medical a little more than a year ago, shared positive results from the ...

Jupiter Endovascular today announced positive results from the first-in-human study of its Vertex pulmonary embolectomy system.

Older adults who have a heart attack may be more likely to develop epilepsy later in life, according to a study published ...

Cindyana Santangelo had an embolism after receiving injections of silicone oil into her buttocks by Libby Adame, the second ...

Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

THROMBOLEX™, Inc. presented the prespecified interim analysis from the first 50 patients in RAPID-PE, a prospective, multicenter U.S. study evaluating On-The-Table (OTT) pharmaco-mechanical lysis (PML ...

Thrombolex, Inc. announced findings from a prespecified interim analysis from the first 50 patients in the postmarket RAPID-PE ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced results from four Late-Breaking ...